Article Details
Retrieved on: 2020-12-18 11:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Dev Mantena, who heads the company's global strategy as well as its speciality generic injectables and <b>synthetic biology</b> divisions, told Reuters.
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here